Use of these marks is for identification and editorial purposes only and does not imply affiliation with or endorsement by the trademark holder
Last update: July 15, 2026 Est
This dual effect of reducing pro-inflammatory immune responses while promoting regulatory mechanisms demonstrates the immunomodulatory potential of GLP-1RAs as one of the disease-modifying agents in treating chronic autoimmune conditions
Theres a typical pattern to the side effects: They tend to occur when you first start taking the GLP-1 or when you increase your dosage, and they should improve and ultimately go away over time as your body adjusts to your treatment
The best part is, its a program that doesnt require any insurance or expensive memberships
Menghaney further urged the inclusion of these therapies in Indias National List of Essential Medicines (NLEM) to unlock government procurement, price caps and ensure wider access for patients. The inclusion in the essential medicines list is very important, as the National List acts as a guiding document for State governments in procuring and distributing medicines at public health facilities, she added
